Role of RNA in Metabolic Stress (Image by ©TheRNABlog).
The RNA-Centric Nexus of
Metabolic Stress: From Transcriptional Reprogramming to Epitranscriptomic
Control
|
Role of RNA in Metabolic Stress (Image by ©TheRNABlog). |
The Landscape of Metabolic Stress
The ability of a cell to sense and adapt to its metabolic
environment is fundamental to life. When homeostatic balance is disrupted,
cells enter a state of metabolic stress, a condition that encompasses a wide
spectrum of physiological and pathological states. Understanding the
multifaceted nature of metabolic stress is crucial, as it represents the
upstream trigger for a cascade of sophisticated molecular responses, many of
which are orchestrated by ribonucleic acid (RNA). The definition of metabolic
stress is context-dependent, varying across biological disciplines, yet these
different perspectives converge on a common set of core cellular perturbations
that are ultimately interpreted by the cell's genetic and regulatory machinery.
Defining Metabolic Stress: A
Context-Dependent Phenomenon
From a physiological standpoint, particularly in the field of
exercise science, metabolic stress is defined as a process occurring in
response to low energy availability during intense physical activity. This
state is characterized by the accumulation of specific metabolites within
muscle cells, including lactate, inorganic phosphate (Pi), and hydrogen ions
(H+). This accumulation is a direct result of
elevated rates of ATP hydrolysis and glycolytic flux required to fuel muscle
contractions. The physiological
consequences are significant and include the stimulation of anabolic hormonal
release (e.g., growth hormone), increased production of reactive oxygen species
(ROS), the induction of a local hypoxic environment due to the compression of
blood vessels, and cell swelling. These factors, driven by
metabolite buildup, are considered primary mechanisms that stimulate muscle
adaptations, including hypertrophy. In a broader cellular and pathophysiological context, the
concept of metabolic stress extends beyond exercise-induced changes. It
represents a more general disruption of cellular homeostasis triggered by a
range of stimuli, including nutrient imbalance—both deprivation and excess—as
well as hypoxia and oxidative stress. This definition is
particularly relevant to the study of chronic diseases. In neurodegenerative
disorders such as Alzheimer's disease (AD), metabolic stress manifests as a
complex interplay of neuroinflammation, insulin resistance, and endoplasmic
reticulum (ER) stress within the brain. Similarly, in metabolic
disorders like type 2 diabetes (T2DM), chronic exposure to high levels of
glucose and lipids (glucolipotoxicity) induces a state of metabolic stress in
tissues like the pancreas, liver, and muscle, driving cellular dysfunction and
pathology. These varied definitions
are not contradictory; rather, they describe different manifestations of a
fundamental problem. High-level physiological events, whether a bout of
resistance training or the progression of a chronic disease, induce a common,
limited set of core cellular states. It is these core states that are directly
sensed by the RNA regulatory machinery, revealing an elegant modularity in the
cell's design. The cell does not require a unique response system for every
conceivable external threat but instead possesses a robust, integrated set of
responses to a few core internal challenges.
The Core Cellular Stressors:
Proximate Triggers of the RNA Response
The diverse physiological phenomena classified as metabolic
stress converge upon a handful of fundamental cellular challenges that serve as
the proximate triggers for the vast network of RNA-mediated responses.
Nutrient
and Energy Imbalance: This is a primary stressor that can manifest as either
nutrient deprivation or nutrient excess. During deprivation, such as caloric
restriction or fasting, cells activate key energy sensors like AMP-activated
protein kinase (AMPK) and switch to more efficient catabolic pathways like
mitochondrial oxidative phosphorylation. While this adaptation maximizes ATP production
from limited resources, it can paradoxically increase the generation of
mitochondrial ROS. Conversely, nutrient excess, a hallmark of
modern metabolic diseases like obesity and T2DM, can overwhelm the cell's
metabolic capacity, leading to ROS production that surpasses antioxidant
defenses, thereby inducing a state of stress. Hypoxia: This condition of insufficient oxygen availability
can be acute and physiological, as seen in exercising muscle, or chronic and
pathological, as found in the microenvironment of solid tumors or in ischemic
tissues following a stroke or heart attack. Hypoxia is a potent activator of a master
transcriptional program mediated by Hypoxia-Inducible Factors (HIFs), which
orchestrate a cellular shift toward anaerobic metabolism and promote
angiogenesis to restore oxygen supply. Oxidative
Stress: This state arises from an imbalance between the production of ROS and
the cell's antioxidant capacity. Mitochondria and enzymes like NADPH oxidases
(NOX) are major sources of ROS. While physiological levels of ROS function as
critical signaling molecules, excessive ROS are highly destructive, causing
damage to all major classes of biological macromolecules, including lipids,
proteins, and, critically, nucleic acids like DNA and RNA. This damage is a key
contributor to the aging process and the pathogenesis of numerous diseases. Endoplasmic Reticulum (ER) Stress: The ER is responsible
for folding a significant portion of the cell's proteins. When the demand for
protein folding exceeds the ER's capacity, unfolded or misfolded proteins
accumulate, triggering a signaling cascade known as the Unfolded Protein
Response (UPR). ER
stress is intimately linked with metabolic status, as nutrient fluctuations and
oxidative stress can disrupt ER function. It is a central component of the
metabolic stress observed in diseases like AD and T2DM, where it contributes to
insulin resistance and inflammation.
The RNA Repertoire: An
Overview of Key Molecular Players
To orchestrate the complex cellular response to metabolic
stress, the cell deploys a diverse and versatile repertoire of RNA molecules.
These range from the canonical players of the central dogma to a vast and
intricate network of non-coding RNAs that function as regulators. An
understanding of this cast of characters is essential to appreciate the multi-layered
nature of the RNA-centric stress response.
The Central Dogma Players:
More Than Just Messengers and Builders
The traditional roles of messenger RNA (mRNA), ribosomal RNA
(rRNA), and transfer RNA (tRNA) as components of the protein synthesis machinery
are well-established. However, under conditions of metabolic stress, these
molecules transcend their housekeeping functions to become active participants
in the regulatory network.
●
Messenger RNA (mRNA): As
the template for protein synthesis, mRNA carries genetic information from the
nucleus to the ribosome. The expression level of
any given protein is a function of not only the transcription rate of its gene
but also the stability and translational efficiency of its mRNA. These latter
two properties are critical, dynamic regulatory nodes that are heavily
modulated during metabolic stress.
●
Ribosomal RNA (rRNA):
Constituting the bulk of cellular RNA, rRNAs are the structural and catalytic
heart of the ribosome, the cellular machine responsible for translation. The catalytic activity of rRNA in forming
peptide bonds marks it as a ribozyme, an RNA molecule with enzymatic function. Far from being inert scaffolds, rRNAs are
direct targets of oxidative damage during stress, which can impair ribosome
function and contribute to the overall decline in protein synthesis.
●
Transfer RNA (tRNA):
These small, highly structured RNAs act as the adaptors that decipher the
genetic code on mRNA and deliver the correct amino acids to the growing
polypeptide chain. tRNAs are subject to
extensive chemical modifications that are vital for their stability and
decoding accuracy. During metabolic stress, these modification patterns can be
altered, and, remarkably, tRNAs can be specifically cleaved by enzymes to
generate smaller tRNA-derived fragments (tRFs). These fragments are not merely
degradation products but are emerging as a new class of regulatory small RNAs
that can inhibit translation and participate in stress signaling pathways. This functional plasticity, where core
components of the translation machinery are repurposed into signaling
molecules, represents a sophisticated layer of cellular adaptation, allowing
the cell to generate new regulatory outputs from existing molecular pools
without the need forde novo gene
expression.
The Non-Coding Universe: A
Symphony of Regulation
●
The discovery that less
than 2% of the human genome encodes proteins has revolutionized molecular
biology, revealing that the majority of the genome is transcribed into
non-coding RNAs (ncRNAs). These molecules, which
function directly as RNAs without being translated into protein, form a complex
regulatory web that governs nearly every aspect of cell biology, and they are
central to the metabolic stress response. Small ncRNAs: This category includes several classes of short RNA molecules.
○
MicroRNAs (miRNAs):
These are short (~22 nucleotide) RNAs that act as post-transcriptional
repressors. They are loaded into an Argonaute protein complex and guide it to
target mRNAs, typically through partial complementarity in the 3' untranslated
region (UTR), leading to mRNA degradation or translational inhibition. miRNAs are critical for fine-tuning entire
gene networks and are key players in orchestrating cellular responses to
metabolic challenges.
○
Small nucleolar RNAs (snoRNAs): Found in the nucleolus, the primary role of snoRNAs is to guide
the chemical modification (e.g., methylation and pseudouridylation) of rRNAs
and other RNAs, a process essential for correct ribosome assembly and function. Like tRNAs, snoRNAs are also being redefined
in the context of stress, where they can be processed into smaller fragments
with distinct regulatory functions and are implicated in the response to
lipotoxicity and oxidative stress.
●
Long non-coding RNAs (lncRNAs): This is a large and heterogeneous class of ncRNAs defined by a
length greater than 200 nucleotides. Their functional
mechanisms are remarkably diverse; they can act as signals, decoys for miRNAs
or proteins, guides that direct chromatin-modifying complexes to specific DNA
loci, or scaffolds that assemble protein complexes. A growing number of lncRNAs are specifically
induced by metabolic stressors and have been identified as pivotal regulators
in the pathogenesis of metabolic diseases.
The following table
provides a summary of these key RNA classes and their dual roles in both
homeostasis and metabolic stress.
|
RNA Class |
Primary Function
(Homeostasis) |
Role/Fate in Metabolic
Stress |
|
mRNA |
Protein-coding
template |
Altered stability and
translational efficiency; direct oxidative damage |
|
rRNA |
Structural and
catalytic core of the ribosome |
Oxidative damage
leading to impaired ribosome function; altered transcription |
|
tRNA |
Adaptor for amino acid
delivery during translation |
Cleavage into regulatory
tRNA-derived fragments (tRFs); altered modification patterns |
|
miRNA |
Post-transcriptional
gene silencing; fine-tuning of gene networks |
Stress-specific
expression (e.g., "hypoxamirs"); regulation of metabolic and
apoptotic pathways |
|
lncRNA |
Diverse regulation
(scaffold, guide, decoy, signal) |
Stress-induced
expression; epigenetic regulation; miRNA sponging; control of stress response
pathways |
|
snoRNA |
Guidance of rRNA/snRNA
chemical modification |
Processing into
smaller regulatory fragments; involvement in oxidative stress response |
Transcriptional
Reprogramming: The First Line of Genomic Defense
The most fundamental and enduring response to sustained
metabolic stress is a profound reprogramming of the cell's transcriptional
landscape. This process involves altering the expression of thousands of genes
to suppress growth-related programs and activate protective and adaptive
pathways. This global shift is orchestrated by a combination of
stress-responsive transcription factors and dynamic changes in the chromatin
environment, which itself acts as a sensor of the cell's metabolic state.
Orchestration by
Stress-Responsive Transcription Factors (TFs)
Transcription factors are proteins that bind to specific DNA
sequences to control the rate of transcription, thereby serving as the primary
actuators of the gene expression response to cellular signals. During metabolic stress, several key TFs are
activated to mount a coordinated defense.
●
Hypoxia-Inducible Factors (HIFs): In response to low oxygen, the HIF-1α subunit is stabilized,
allowing it to dimerize with the constitutive HIF-1β subunit. This complex then
translocates to the nucleus, where it binds to DNA sequences known as Hypoxia
Response Elements (HREs) in the promoters of target genes. This activates a broad transcriptional program
that promotes adaptation to hypoxia, including the upregulation of genes
involved in anaerobic glycolysis, angiogenesis (e.g.,VEGF), and erythropoiesis.
●
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2): Nrf2 is the master regulator of the antioxidant response. Under homeostatic conditions, it is
sequestered in the cytoplasm and targeted for degradation by the protein KEAP1.
Oxidative stress disrupts this interaction, allowing Nrf2 to accumulate in the
nucleus and activate the transcription of a battery of cytoprotective genes
that contain Antioxidant Response Elements (AREs) in their promoters. This response bolsters the cell's antioxidant
defenses and detoxification capacity. Notably, this pathway is linked to
metabolic sensing, as the energy sensor AMPK is required for the maximal
transcriptional activation of Nrf2 targets.
●
Activating Transcription Factor 4 (ATF4): As a central effector of the Integrated Stress Response (ISR),
ATF4 is primarily regulated at the level of translation (discussed in Section
4.1). However, once synthesized, it functions as a potent transcription factor.
ATF4 drives the expression of genes crucial for adapting to stress, including
those involved in amino acid biosynthesis and transport, antioxidant responses,
and ER chaperones. If the stress is severe and prolonged, the ATF4 program can
switch from pro-survival to pro-apoptotic, initiating cell death.
Chromatin as a
Metabolic Sensor
The accessibility of genes for transcription is governed by the
physical state of chromatin, the complex of DNA and histone proteins. This
landscape is dynamically regulated by a series of post-translational
modifications on histone tails and chemical modifications on DNA itself. A profound link between metabolism and gene
expression arises from the fact that the enzymes responsible for writing and
erasing these epigenetic marks use key intermediary metabolites as essential
substrates and cofactors.
This direct biochemical linkage means that the cell's metabolic
state is translated into its epigenetic state, influencing its transcriptional
potential. Key examples include:
●
Acetylation: Histone acetylation, a
mark generally associated with active transcription, is catalyzed by histone
acetyltransferases (HATs) that use acetyl-CoA
as the acetyl group donor. Cellular levels of acetyl-CoA are directly dependent
on the metabolism of glucose, fatty acids, and acetate, thus linking nutrient
availability directly to gene activation potential.
●
Methylation: Histone and DNA
methylation reactions, which can be either activating or repressive depending
on the site, are catalyzed by methyltransferases that use S-adenosylmethionine (SAM) as the universal methyl donor. The SAM
pool is maintained by the methionine cycle and one-carbon metabolism, pathways
that are sensitive to the availability of specific amino acids and vitamins.
●
Demethylation: A
large class of demethylases, including the TET enzymes that hydroxylate
methyl-cytosine in DNA and the JmjC-domain histone demethylases, are
α-ketoglutarate-dependent dioxygenases. They require α-ketoglutarate (αKG), a central intermediate of the TCA cycle, as
a co-substrate. Consequently, their
activity is sensitive to the balance between glycolysis and oxidative
phosphorylation. Furthermore, they are competitively inhibited by metabolites
like succinate, fumarate, and the oncometabolite D-2-hydroxyglutarate (D-2HG),
which accumulate in certain metabolic diseases and cancers, leading to
widespread hypermethylation and altered gene expression.
This intricate
connection establishes a powerful feedback mechanism. The cell's metabolic
state alters the availability of these key metabolites, which in turn modulates
the activity of chromatin-modifying enzymes. The resulting changes in the chromatin
landscape then regulate the expression of genes, including those encoding
metabolic enzymes, thus reinforcing the initial metabolic state. This
self-perpetuating loop can explain the stability of pathological metabolic
states, such as the Warburg effect in cancer, and highlights the challenge in
reversing them. Breaking this cycle may require therapeutic strategies that
target both metabolic and epigenetic components simultaneously.
Global Transcriptomic Shifts
in Response to Stress
The
advent of high-throughput technologies like microarrays and RNA-sequencing has
enabled an unbiased, genome-wide view of the transcriptional response to
stress. These
transcriptomic studies have revealed that diverse stressors induce a common,
coordinated program of gene expression changes. This typically involves the
rapid induction of cytoprotective genes—such as molecular chaperones,
antioxidant enzymes, and DNA repair factors—coupled with the widespread
repression of genes associated with cell growth, proliferation, and anabolic
metabolism. In the context of human disease,
transcriptomic analyses of postmortem brain tissue from individuals with major
depressive disorder (MDD) and post-traumatic stress disorder (PTSD)—conditions
strongly linked to chronic stress—have uncovered significant dysregulation of
gene networks. These networks are involved in synaptic function, neurotrophic
factor signaling (e.g., BDNF), and the glucocorticoid response system. These studies have
also revealed striking sex-specific differences in the transcriptomic
signatures of these disorders, suggesting that males and females may utilize
different molecular pathways in their response to chronic stress. The increasing use
of single-cell and single-nucleus RNA-sequencing (scRNA-seq and snRNA-seq) is
providing unprecedented resolution, allowing researchers to dissect the
cell-type-specific transcriptional responses within complex tissues, further
refining our understanding of how metabolic stress impacts organismal health.
Post-Transcriptional Regulation:
Fine-Tuning the Stress Response
While transcriptional reprogramming establishes a new, long-term
cellular state, it is a relatively slow process. To survive acute, transient
stress, cells rely on a suite of faster, more dynamic post-transcriptional
regulatory mechanisms. These processes act on RNA transcripts after they have
been synthesized, controlling their translation, localization, and stability.
This allows for a rapid and reversible modulation of gene expression, providing
an immediate defense that buys time for the more profound transcriptional
changes to take effect. This temporal layering of responses is a hallmark of a
sophisticated and robust cellular defense system. An initial, rapid response
based on post-transcriptional controls stabilizes the cell and mitigates
immediate damage, while the slower, more comprehensive transcriptional program
reconfigures the cell for long-term adaptation or survival.
|
Mechanism |
Key Molecular Players |
Primary Stress
Triggers |
Typical Response
Timescale & Outcome |
|
Translational Control via ISR |
eIF2α kinases (PERK,
GCN2, HRI, PKR), ATF4 |
ER stress, amino acid
deprivation, oxidative stress, viral infection |
Minutes; Global
translation halt & selective translation of stress mRNAs |
|
RNA Sequestration |
G3BP1, TIA-1, other
RBPs |
Translational stall
(ISR, mTOR inhibition) |
Minutes; mRNA triage
and protection in Stress Granules |
|
SR proteins, hnRNPs |
Hypoxia, cell
signaling, heat shock |
Minutes to hours;
Proteome diversification, production of stress-specific isoforms |
|
|
mRNA Stability Control |
RNA-Binding Proteins
(RBPs), 3' UTR elements, RNA surveillance machinery |
Oxidative stress,
specific signaling cues |
Minutes; Rapid
fine-tuning of specific transcript levels, degradation of damaged RNAs |
The Integrated Stress
Response (ISR): A Central Hub for Translational Control
The Integrated Stress
Response (ISR) is a pivotal signaling pathway that acts as a central command
center for translational control during stress. It is activated by a remarkably diverse set of
stressors, which are detected by four distinct eIF2α kinases. Each kinase
possesses unique regulatory domains that allow it to sense a specific type of
cellular imbalance, yet they all converge on a single downstream event: the
phosphorylation of the α subunit of eukaryotic translation initiation factor 2
(eIF2α) on serine 51.
|
Kinase |
Primary Activating
Stress Signal(s) |
Cellular Location |
Downstream Consequence
Beyond eIF2α Phosphorylation |
|
PERK |
ER stress (unfolded
proteins), glucose deprivation, redox imbalance |
ER Membrane |
Activates the full
Unfolded Protein Response (UPR) signaling cascade |
|
GCN2 |
Amino acid starvation
(sensed via uncharged tRNAs), UV light |
Cytosol |
Directly links
nutrient availability to translational control |
|
HRI |
Heme deficiency,
oxidative stress, heat shock, proteasome inhibition |
Cytosol |
Couples globin
synthesis to heme availability in erythroid cells |
|
PKR |
Viral double-stranded
RNA (dsRNA), other cellular stresses |
Cytosol |
Key sensor in the
innate antiviral immune response |
The
phosphorylation of eIF2α has a profound, bifurcated effect on protein
synthesis. It converts eIF2 into a potent inhibitor of its own recycling
factor, eIF2B, thereby drastically reducing the global rate of translation
initiation. This rapid shutdown conserves cellular energy and prevents the
synthesis of new proteins under potentially error-prone conditions. Simultaneously, this
global attenuation enables the selective translation of a small subset of
mRNAs, most notably that of the transcription factor ATF4. These specialized
mRNAs contain regulatory elements called upstream open reading frames (uORFs)
in their 5' leaders, which allow them to be efficiently translated precisely
when the machinery is stalled, thus activating the downstream transcriptional
arm of the stress response. Stress
Granules (SGs): Dynamic Hubs for mRNA Triage
A
direct consequence of the widespread translational arrest initiated by the ISR
is the formation of Stress Granules (SGs). These are dense, non-membranous
cytoplasmic bodies formed by the liquid-liquid phase separation of stalled
translation pre-initiation complexes, untranslated mRNAs, and a host of
RNA-binding proteins (RBPs). SGs are not static aggregates but highly
dynamic compartments that serve as centers for mRNA triage. They function to
sequester and protect the bulk of the cell's "housekeeping" mRNAs
from degradation during the stress period. Upon resolution of the stress, SGs
rapidly dissolve, releasing the stored mRNAs to re-engage with ribosomes, which
facilitates a swift return to normal protein synthesis and cellular function. In addition to this
storage function, SGs also act as signaling hubs, concentrating signaling
molecules and enzymes, such as the kinase PKR, to amplify the stress response. Alternative Splicing (AS) Under Duress
Alternative
splicing is a fundamental post-transcriptional process that dramatically
expands the coding capacity of the genome. By differentially including or
excluding exons from a pre-mRNA transcript, a single gene can give rise to
multiple distinct protein isoforms, often with different functions,
localizations, or stabilities. This process is not static but is dynamically
regulated in response to cellular signals and environmental cues. Metabolic
stressors, particularly hypoxia, are potent modulators of alternative splicing. Studies have shown
that hypoxia can trigger thousands of alternative splicing events, profoundly
altering the cellular proteome. These stress-induced splicing changes are
mediated by alterations in the expression, localization, or activity of core
splicing regulators, such as the Serine/Arginine-rich (SR) proteins and
heterogeneous nuclear ribonucleoproteins (hnRNPs). The consequences of stress-induced AS can be adaptive or
pathological. For example, splicing changes can generate protein isoforms that
promote cell survival under hypoxic conditions. However, chronic or aberrant
splicing is a hallmark of disease. In neurodegeneration, hypoxia-induced
changes in the splicing of APP and tau pre-mRNAs can promote the production
of the toxic protein variants that drive Alzheimer's disease pathology. In oncology,
hypoxia-induced alternative splicing is now recognized as a major driver of
tumor progression, angiogenesis, and metastasis, and the splicing machinery
itself is being explored as a therapeutic target. mRNA Stability and Turnover: Regulating Transcript Half-Life
The
abundance of a protein is determined not only by its rate of synthesis but also
by the degradation rate of its corresponding mRNA. The regulation of mRNA
stability, or half-life, is therefore a critical layer of post-transcriptional
control that allows for rapid adjustments in gene expression. The stability of an
mRNA is often dictated by specific sequence elements within its 3' UTR, which
serve as binding sites for various RBPs that can either protect the transcript
from degradation (e.g., HuR) or target it to decay pathways (e.g., AUF1). Oxidative stress has a particularly profound impact on mRNA
stability. RNA molecules are highly susceptible to damage by ROS, with the
hydroxyl radical (OH•) being a major culprit. The most common form
of oxidative RNA damage is the conversion of guanosine to 8-hydroxyguanosine
(8-OHG). The
presence of such lesions on an mRNA can cause ribosomes to stall during
translation, leading to reduced protein output. To prevent the
accumulation of damaged transcripts and the potential production of aberrant
proteins, cells have evolved sophisticated RNA surveillance pathways. These
systems, analogous to nonsense-mediated decay (NMD), recognize and rapidly
degrade oxidized mRNAs. In
some cases, specific RNA structures, such as RNA G-quadruplexes (rG4s), can
function as direct ROS sensors; oxidative damage to the structure leads to its
unfolding and subsequent destabilization of the entire
mRNA molecule.
The Epitranscriptome: A New
Frontier in Stress Regulation
Beyond the regulation of transcription and processing, a further
layer of control exists directly on the RNA molecules themselves: the
epitranscriptome. This refers to the collective of over 140 distinct,
enzymatically catalyzed chemical modifications that adorn RNA, creating a
dynamic regulatory code that influences every step of an RNA's life cycle. This
field has revealed that RNA is not just a passive carrier of information but is
actively decorated with marks that are written, erased, and read to control
gene expression in response to cellular cues.
An Introduction to RNA
Modifications: The "Writers, Readers, and Erasers"
●
The epitranscriptome is
managed by a dedicated set of proteins that function in a manner analogous to
the epigenetic machinery that modifies chromatin. Writers are enzymes, such as
methyltransferases, that install a specific chemical mark onto an RNA
nucleotide. A prime example is the METTL3-METTL14 complex, which catalyzes the
m6A modification.
●
Erasers are enzymes that remove
these marks, allowing the process to be reversible and dynamic. The FTO and
ALKBH5 proteins, for instance, are demethylases that remove the m6A mark.
●
Readers are proteins that
contain specialized domains to specifically recognize and bind to a modified
nucleotide. This binding event is what translates the chemical mark into a
biological outcome, such as altering the RNA's stability, localization,
splicing, or translation. The YTH-domain family of proteins are
well-characterized readers of m6A.
The
dysregulation of this machinery is increasingly linked to a wide array of human
diseases, including cancer, neurological disorders, and metabolic diseases. N6-methyladenosine (m6A): The Preeminent mRNA Mark
Among the many RNA modifications, N6-methyladenosine (m6A) is
the most abundant and well-studied internal modification on eukaryotic mRNA. It is typically deposited within a consensus
sequence motif (RRACH, where R=A/G, H=A/C/U) and is enriched in specific
transcript regions, such as near stop codons and within long internal exons and
3' UTRs. The
m6A pathway is a critical regulator of the cellular response to metabolic
stress. Its role is particularly prominent in the
control of lipid metabolism and associated pathologies like obesity and
non-alcoholic fatty liver disease (NAFLD). The gene encoding the m6A
eraser FTO was famously the first to be identified as a major obesity-risk
locus through genome-wide association studies. Mechanistically, FTO can promote
adipogenesis and lipid accumulation by removing m6A marks from the mRNAs of key
lipogenic transcription factors, such as
PPARγ and SREBP1c. This
demethylation increases the stability of these transcripts, leading to higher
protein levels and enhanced fat storage. The functional outcome of
an m6A mark is context-dependent and determined by the specific reader protein
that binds it. For example, binding by the reader YTHDF2 often targets the
m6A-modified mRNA for accelerated degradation, whereas binding by YTHDF1 can
enhance its translation. A particularly elegant principle of cellular regulation is
revealed by the co-regulation of the epigenome and the epitranscriptome. The
enzymes that control these two systems are often dependent on the same pool of
intermediary metabolites. For instance, the m6A writer METTL3 uses SAM as its
methyl donor, the same metabolite used by histone and DNA methyltransferases.
Similarly, the m6A erasers FTO and ALKBH5 are αKG-dependent dioxygenases, just
like the TET and JmjC demethylases that act on chromatin. This means that a
single metabolic shift, such as a decrease in αKG levels during hypoxia, can
simultaneously inhibit demethylation of both histones and RNA. This creates a
powerful, coordinated, multi-layered response that ensures the cell's entire
gene expression program, from transcription to RNA fate, is coherently
modulated by its metabolic state. This deep integration underscores that these
are not separate systems but rather two arms of a single, integrated network
responding to the same upstream metabolic signals.
Other Key Modifications and
RNA Editing
While m6A is the most studied mRNA modification, other
epitranscriptomic marks and processes are also vital for the stress response.
●
Adenosine-to-Inosine (A-to-I) Editing: This process, catalyzed by the ADAR family of enzymes, converts
adenosine to inosine within regions of double-stranded RNA. Since the cellular machinery interprets
inosine as guanosine, this modification can have profound effects, including
altering protein-coding sequences, creating or removing splice sites, and
changing the targeting specificity of miRNAs. A-to-I editing is essential for normal
neurological function and has been implicated in the response to oxidative
stress.
●
Pseudouridylation (Ψ): This
is the enzymatic isomerization of uridine into a different isomer,
pseudouridine. This modification can alter the structure of RNA and has been
shown to enhance the stability and translational efficiency of mRNA. The strategic incorporation of pseudouridine
into synthetic mRNAs was a breakthrough that enabled the development of the
highly stable and effective mRNA vaccines for COVID-19.
It is
critical to distinguish these precise, enzyme-catalyzed regulatory events from
the stochastic damage that RNA sustains from uncontrolled oxidative stress.
Programmed RNA editing and modification are sophisticated mechanisms of gene
regulation, whereas oxidative RNA damage is a pathological event that the cell
must either repair or eliminate.
Non-Coding RNAs as Master
Regulators of Metabolic Homeostasis
Within the vast non-coding transcriptome, microRNAs (miRNAs) and
long non-coding RNAs (lncRNAs) stand out as particularly influential regulators
of the metabolic stress response. They form complex networks that interpret
stress signals and execute specific gene expression programs, acting as both
fine-tuners and master switches of cellular fate. A functional duality appears
to exist between these two classes: miRNAs generally act as rheostats,
providing subtle, network-wide adjustments to maintain stability, while lncRNAs
often function as architects, orchestrating major, decisive shifts in cell
state.
MicroRNAs (miRNAs):
Fine-Tuning Metabolic Networks
miRNAs are small non-coding RNAs that function as
post-transcriptional repressors, typically by binding to the 3' UTR of target
mRNAs to trigger their degradation or inhibit their translation. A single miRNA can regulate hundreds of
different target genes, allowing them to act as powerful rheostats that
fine-tune the output of entire metabolic pathways and signaling networks. Their expression is highly dynamic and
responsive to metabolic cues, and their dysregulation is a common feature of
metabolic diseases. Hypoxia is a particularly potent regulator of miRNA expression
and function. It induces a
characteristic set of miRNAs, collectively termed "hypoxamirs," which
play a central role in cellular adaptation to low oxygen. The canonical
hypoxamir is
miR-210, which is directly transcribed in response to HIF-1α
activation. miR-210 orchestrates the metabolic switch toward glycolysis by
targeting and repressing key components of the mitochondrial TCA cycle and
electron transport chain, thereby suppressing oxygen consumption and promoting
cell survival under hypoxic conditions. Beyond hypoxia, miRNAs are critical regulators of glucose and
lipid homeostasis. For example:
●
miR-33a and miR-33b are
located within the introns of the genes encoding the SREBP transcription
factors, the master regulators of cholesterol and fatty acid synthesis. The
miRNAs are co-transcribed with their host genes and act in concert with them to
control lipid metabolism, creating a coherent feed-forward regulatory loop.
●
miR-375 is highly expressed in
pancreatic islets and is a key regulator of insulin secretion and the
maintenance of β-cell mass. Its dysregulation is strongly implicated in the
pathogenesis of diabetes.
●
miR-34a is induced in
pancreatic β-cells by lipotoxic stress (exposure to high levels of saturated
fatty acids) and promotes apoptosis by repressing the anti-apoptotic protein
Bcl2, thus contributing to β-cell loss in T2DM.
Because
they are stable molecules that can be detected in circulating biofluids like
blood plasma, miRNAs are also emerging as highly promising non-invasive
biomarkers for monitoring metabolic stress and disease progression. Long Non-Coding RNAs (lncRNAs): Versatile Orchestrators of the Stress
Response
lncRNAs are a large and functionally diverse class of
transcripts that have emerged as major players in the regulation of cellular
stress responses, including metabolic, oxidative, and genotoxic stress. They achieve their regulatory effects through
a wide array of molecular mechanisms. In the nucleus, many lncRNAs function as
guides or scaffolds, recruiting chromatin-modifying complexes like Polycomb
Repressive Complex 2 (PRC2) to specific gene loci to epigenetically silence
their expression. In the cytoplasm, they
can act as "sponges" or decoys for miRNAs, binding and sequestering
them to prevent them from repressing their own mRNA targets. Numerous lncRNAs have
been specifically implicated in metabolic stress and disease:
●
MALAT1 is upregulated in the
context of diabetic complications and has been shown to promote hepatic
steatosis (fatty liver) and insulin resistance. It also contributes to
hyperglycemia-induced damage in retinal cells, linking it to diabetic
retinopathy.
●
GAS5 (Growth Arrest-Specific 5) often functions as a tumor suppressor and is involved in the
cellular response to nutrient deprivation by modulating key pathways like
autophagy and apoptosis.
●
H19 is an imprinted lncRNA
that plays a complex role in hepatic glucose metabolism; its inhibition has
been shown to impair insulin signaling and increase the expression of
gluconeogenic genes.
Stress-responsive
lncRNAs are now understood to be critical mediators of the pathological effects
of hyperglycemia-induced oxidative and ER stress, which are the primary drivers
of diabetic complications such as nephropathy (kidney disease) and retinopathy
(eye disease). This regulatory
duality—miRNAs as fine-tuners and lncRNAs as master switches—suggests a
sophisticated division of labor in the cell's regulatory architecture, with
different therapeutic implications. Re-balancing a dysregulated pathway might
be achieved by targeting a miRNA, whereas reversing a pathologically entrenched
cell state might require intervention at the level of a key lncRNA.
Integration and
Pathophysiological Implications
The intricate RNA-based regulatory mechanisms described—from
transcriptional reprogramming to post-transcriptional control and
epitranscriptomic marking—do not operate in isolation. They are woven into a
cohesive network that is coordinated by master signaling hubs, which integrate
information about the cell's metabolic state and direct the appropriate
response. The chronic dysregulation of this integrated network is a fundamental
driver of pathology in a host of human diseases. Understanding this
system-level behavior is key to developing effective therapeutic strategies.
Signaling Hubs: The AMPK/mTOR
Axis
●
At the heart of cellular
metabolic regulation lie two evolutionarily conserved protein kinase signaling
pathways: the AMP-activated protein kinase (AMPK) pathway and the mechanistic
target of rapamycin (mTOR) pathway. These two hubs act as a central processing
unit, sensing the cell's energy and nutrient status and making critical
decisions about cellular growth and metabolism. They function as
counter-regulators: AMPK is the guardian of catabolism, while mTOR is the
governor of anabolism. AMPK (The Energy
Sensor): AMPK is activated by conditions of low
cellular energy, signified by a high ratio of AMP to ATP, such as during
exercise or nutrient deprivation. Once active, AMPK
phosphorylates a multitude of substrates to switch on catabolic, ATP-producing
pathways (like fatty acid oxidation and autophagy) and switch off anabolic,
ATP-consuming processes (like protein and lipid synthesis).
●
mTOR (The Nutrient Sensor): The
mTOR kinase is the core component of two distinct protein complexes, mTORC1 and
mTORC2. mTORC1 is the primary nutrient-sensing complex, activated by high
levels of nutrients (especially amino acids) and growth factors. Active mTORC1 drives cell growth and
proliferation by promoting anabolic pathways and potently inhibiting catabolic
processes like autophagy.
Crucially, the influence
of AMPK and mTOR extends far beyond the direct phosphorylation of metabolic
enzymes. These kinases are deeply intertwined with the RNA regulatory
machinery. Both kinases can
translocate to the nucleus, where they directly phosphorylate transcription
factors and chromatin-modifying enzymes to control gene expression programs. They also exert powerful control over the
translation machinery through phosphorylation of key targets like S6 kinase
(S6K) and 4E-binding protein 1 (4E-BP1), which in turn dictates global protein
synthesis rates and the formation of stress granules. The interplay between these two pathways is
managed by extensive reciprocal inhibition: AMPK directly phosphorylates and
inhibits mTORC1, while mTORC1 can phosphorylate and suppress AMPK, creating a
sensitive molecular switch that fine-tunes the cell's metabolic posture. Dysregulation in Disease:
When Adaptation Becomes Pathology
●
While the activation of
these RNA-centric stress responses is essential for surviving acute challenges,
their chronic, unabated activation in the face of persistent metabolic stress
is a primary driver of disease. Metabolic Syndrome and
T2DM: The state of chronic hyperglycemia and
hyperlipidemia (glucolipotoxicity) that characterizes T2DM and metabolic
syndrome creates a vicious cycle of persistent ER stress and oxidative stress.
This leads to the pathological dysregulation of numerous ncRNAs. For instance,
specific miRNAs and lncRNAs are induced that promote pancreatic β-cell
apoptosis, drive insulin resistance in peripheral tissues, and fuel chronic
low-grade inflammation. Furthermore,
dysregulation of the m6A epitranscriptomic machinery, particularly involving
the obesity-associated geneFTO, is a
key contributor to aberrant lipid metabolism and insulin resistance.
●
Neurodegenerative Diseases: The
proper regulation of RNA processing is paramount for the health and function of
long-lived, post-mitotic cells like neurons, and its dysregulation is a common
theme in neurodegenerative diseases such as AD, Parkinson's disease, and ALS. Metabolic stress is a major risk factor for
these conditions, contributing to pathology through multiple RNA-based
mechanisms, including aberrant alternative splicing of disease-relevant genes
liketau and APP ,
direct oxidative damage to RNA molecules , and
the dysregulation of epitranscriptomic marks that are essential for synaptic
function and neuronal survival.
●
Cancer: Cancer cells must
survive and proliferate within the harsh and metabolically stressful tumor
microenvironment, which is often characterized by hypoxia and nutrient
limitation. To do so, they hijack and co-opt the cell's innate stress response
pathways. They undergo profound metabolic reprogramming (e.g., the Warburg
effect) and become dependent on stress-activated ncRNAs and other RNA
regulators to evade apoptosis, sustain proliferation, and enable invasion and
metastasis.
The table below
highlights select non-coding RNAs whose dysregulation in specific metabolic
stress contexts contributes to disease.
|
ncRNA Name |
Class |
Metabolic Stress
Context |
Key
Target(s)/Mechanism |
Contribution to
Pathology |
|
miR-34a |
miRNA |
Lipotoxicity (high
fatty acids) |
Targets anti-apoptotic
Bcl2 and insulin secretion factor VAMP2 |
Promotes pancreatic
β-cell apoptosis in T2DM |
|
miR-210 |
miRNA |
Hypoxia |
Induced by HIF-1α;
targets mitochondrial OXPHOS components |
Drives glycolytic
switch in tumors, promoting survival and angiogenesis |
|
MALAT1 |
lncRNA |
Hyperglycemia,
Lipotoxicity |
Promotes hepatic
steatosis; may sponge miRNAs |
Contributes to
diabetic retinopathy and insulin resistance |
|
GAS5 |
lncRNA |
Nutrient deprivation |
Modulates autophagy
and apoptosis via mTOR signaling pathway |
Acts as a tumor suppressor;
its loss contributes to cancer progression |
Therapeutic Horizons:
Targeting RNA Pathways
●
The central and causal
role of RNA dysregulation in metabolic disease makes these pathways highly
attractive for therapeutic intervention. A new generation of
RNA-based medicines is emerging that can directly target RNA molecules with
high specificity, moving beyond traditional small molecule and antibody drugs. Oligonucleotide Therapeutics:
Synthetic strands of nucleic acids, such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs), can be designed to bind to a
specific mRNA or lncRNA via complementary base pairing. This binding can
trigger the transcript's degradation or modulate its splicing, effectively
silencing a disease-causing gene. The development of chemical modifications and
delivery technologies, such as conjugation to N-acetylgalactosamine (GalNAc)
for liver-specific uptake, has led to approved therapies for several genetic
liver metabolic diseases.
●
mRNA Therapy: As
famously demonstrated by the COVID-19 vaccines, lipid nanoparticles can be used
to deliver synthetic mRNA into cells, instructing them to produce a specific
protein. This approach holds great promise for protein replacement therapies in
rare genetic diseases and offers a potentially safer alternative to viral
vector-based gene therapy due to a reduced risk of genomic integration.
●
Targeting ncRNAs:
Strategies are being developed to therapeutically modulate ncRNAs.
"Antagomirs" are modified oligonucleotides that can bind to and
inhibit an overactive miRNA, while synthetic miRNA "mimics" can be
delivered to restore the function of a miRNA that is lost in a disease state.
Despite this promise, significant challenges remain, including
the development of efficient methods for delivering these drugs to tissues
beyond the liver, ensuring their long-term safety and efficacy, and addressing
the high manufacturing costs associated with these advanced therapies. The profound
interconnectedness of the pathways involved in the metabolic stress response
suggests that the most powerful therapeutic strategies may be those that target
not a single downstream effector molecule, but a critical regulatory node that
controls the entire network's state. The AMPK/mTOR signaling axis is a prime
example of such a node. Modulating the activity of AMPK or mTOR with a small
molecule drug has the potential to coordinately reset multiple downstream arms
of the RNA-based response—rebalancing miRNA profiles, altering lncRNA
expression, and shifting translational programs—in a holistic manner. This
shifts the therapeutic paradigm from a "one gene, one drug" approach
to a "one network, one drug" philosophy, highlighting the future
importance of systems biology in developing treatments for complex, multifactorial
diseases.
Conclusion
The cellular response to metabolic stress is a masterclass in
regulatory complexity, orchestrated in large part by the diverse and dynamic
world of RNA. Far from being a simple linear pathway, the response is a
multi-layered, interconnected network where RNA acts as a central processor,
sensing core cellular perturbations and executing a sophisticated, temporally
organized defense. Transcriptional reprogramming, driven by stress-responsive
transcription factors and a chromatin landscape that directly senses the cell's
metabolic state, establishes a new, long-term cellular identity. This
foundational change is preceded and supported by a suite of rapid
post-transcriptional mechanisms—including translational control via the Integrated
Stress Response, mRNA triage in stress granules, and dynamic changes in
alternative splicing and stability—that allow the cell to weather acute
insults.
Layered on top of this is the epitranscriptome, a dynamic
chemical code written onto RNA itself, which is co-regulated with the epigenome
by the same intermediary metabolites, ensuring a coherent, system-wide
response. This entire network is fine-tuned and directed by non-coding RNAs,
with miRNAs acting as rheostats to buffer pathways and lncRNAs acting as
architects to execute major shifts in cell fate. The integration of these
RNA-centric pathways by master signaling hubs like the AMPK/mTOR axis
underscores the holistic nature of the cellular response.
While these adaptive responses are essential for survival, their
chronic dysregulation is a fundamental driver of modern human diseases, from
T2DM and neurodegeneration to cancer. The elucidation of these RNA-based
mechanisms has not only transformed our understanding of disease pathogenesis
but has also opened up exciting new therapeutic frontiers. The development of
RNA-based medicines and strategies to target the central nodes of these
regulatory networks holds immense promise for treating these complex and
debilitating conditions. The future of medicine will undoubtedly involve a
deeper appreciation for, and a more precise manipulation of, the RNA-centric
nexus of metabolic stress.
#Hashtags
#RNA #MetabolicStress #GeneRegulation #CellularStress #Transcriptomics #Epitranscriptome #m6A #ncRNA #miRNA #lncRNA #Hypoxia #OxidativeStress #NutrientSensing #IntegratedStressResponse #AlternativeSplicing #mRNAStability #AMPK #mTOR #Diabetes #Neurodegeneration #CancerMetabolism #RNATherapeutics #CellBiology #MolecularBiology
References
1.
Role
of metabolic stress for enhancing muscle adaptations: Practical ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC5489423/
2.
What
Is Metabolic Stress? - Proathlix, https://proathlix.com/blogs/knowledge/what-is-metabolic-stress
3.
Cellular
metabolic stress: Considering how cells respond to nutrient excess - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC3190402/
4.
Endocytosis
in the adaptation to cellular stress - Cell Stress, http://www.cell-stress.com/researcharticles/2020a-lopez-hernandez-cell-stress/
5.
Brain
metabolic stress and neuroinflammation at the basis of cognitive impairment in
Alzheimer's disease - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC4436878/
6.
RNA
Regulation of Lipotoxicity and Metabolic Stress - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4915576/
7.
Nutrient
Sensing and the Oxidative Stress Response - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC5438757/
8.
ROS
signaling under metabolic stress: cross-talk between AMPK and AKT pathway, https://d-nb.info/1130955117/34
9.
Hypoxia-induced
alternative splicing: the 11th Hallmark of Cancer - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC7294618/
10.
Short-Term
Hypoxia in Cells Induces Expression of Genes Which Are Enhanced in Stressed
Cells - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC9498350/
11.
Hypoxia-induced
alternative splicing in human diseases: the pledge, the turn, and the prestige
- PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC11072330/
12.
Oxidative
damage to RNA: mechanisms, consequences, and ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC3010397/
13.
The
role of oxidative stress in the dysregulation of gene expression and protein
metabolism in neurodegenerative disease - PubMed, https://pubmed.ncbi.nlm.nih.gov/16487048/
14.
What
are the functions of rRNA, tRNA, mRNA? - Quora, https://www.quora.com/What-are-the-functions-of-rRNA-tRNA-mRNA
15.
Biochemistry,
RNA Structure - StatPearls - NCBI Bookshelf, https://www.ncbi.nlm.nih.gov/books/NBK558999/
16.
Ribonucleic
Acid (RNA) Fact Sheet, https://www.genome.gov/about-genomics/educational-resources/fact-sheets/ribonucleic-acid-fact-sheet
17.
Post-transcriptional
regulation in metabolic diseases - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC3495744/
18.
Post-transcriptional
regulation during stress - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC9246287/
19.
Coding
and Non-Coding RNA - Bio-Rad, https://www.bio-rad.com/en-us/applications-technologies/coding-non-coding-rna?ID=Q1070M70KWE7
20.
RNA -
Wikipedia, https://en.wikipedia.org/wiki/RNA
21.
Types
of RNA (article) | Khan Academy, https://www.khanacademy.org/test-prep/mcat/biomolecules/x04f6bc56:transcription-and-translation/a/types-of-rna
22.
Different
types of RNAs and their functions - FutureLearn, https://www.futurelearn.com/info/courses/translational-research/0/steps/14201
23.
Noncoding
RNA molecules | EBSCO Research Starters, https://www.ebsco.com/research-starters/health-and-medicine/noncoding-rna-molecules
24.
Roles
of RNA in Biology - RNA Therapeutics Institute - UMass Chan Medical School, https://www.umassmed.edu/rti/biology/what-is-rna/role-of-rna-in-biology/
25.
Non-coding
RNA - Wikipedia, https://en.wikipedia.org/wiki/Non-coding_RNA
26.
MicroRNAs
in Metabolism and Metabolic Disorders - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4021399/
27.
New
regulation mechanisms of natural products and microRNA on metabolic syndrome, https://www.spkx.net.cn/EN/abstract/abstract39422.shtml
28.
Long
Noncoding RNAs in Metabolic Syndrome Related Disorders - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC5110871/
29.
Long
non-coding RNAs: roles in cellular stress responses and epigenetic mechanisms
regulating chromatin, https://pmc.ncbi.nlm.nih.gov/articles/PMC11123517/
30.
Full
article: Long non-coding RNAs: roles in cellular stress responses and
epigenetic mechanisms regulating chromatin, https://www.tandfonline.com/doi/full/10.1080/19491034.2024.2350180
31.
Long
Non-coding RNAs: Major Regulators of Cell Stress in Cancer - PMC - PubMed
Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC7099402/
32.
Long
Non-coding RNAs: Major Regulators of Cell Stress in Cancer - PubMed, https://pubmed.ncbi.nlm.nih.gov/32266130/
33.
Hypoxia:
A master regulator of microRNA biogenesis and activity ..., https://msesiom2.demo.elsevierpure.com/en/publications/hypoxia-a-master-regulator-of-microrna-biogenesis-and-activity
34.
Mastering
Transcriptional Regulation, https://www.numberanalytics.com/blog/mastering-transcriptional-regulation-molecular-cell-signaling
35.
New
insights into transcriptional reprogramming during cellular ..., https://journals.biologists.com/jcs/article/132/21/jcs238402/224639/New-insights-into-transcriptional-reprogramming
36.
Hypoxia-Induced
Alternative Splicing in Endothelial Cells | PLOS One, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0042697
37.
The
Regulation of Integrated Stress Response Signaling Pathway on Viral Infection
and Viral Antagonism - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC8874136/
38.
The
integrated stress response | EMBO reports - EMBO Press, https://www.embopress.org/doi/10.15252/embr.201642195
39.
Metabolic
regulation of chromatin modifications and gene ..., https://rupress.org/jcb/article/217/7/2247/39126/Metabolic-regulation-of-chromatin-modifications
40.
Stress
and its impact on the transcriptome - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC8213869/
41.
Circulating
cell-free RNA signatures for the characterization and diagnosis of myalgic
encephalomyelitis/chronic fatigue syndrome | PNAS, https://www.pnas.org/doi/10.1073/pnas.2507345122
42.
The
Stress Granule Protein G3BP1 Recruits Protein Kinase R To Promote Multiple
Innate Immune Antiviral Responses - ASM Journals, https://journals.asm.org/doi/10.1128/jvi.02791-14
43.
non-stop
decay mRNA surveillance pathway is required for oxidative stress tolerance |
Nucleic Acids Research | Oxford Academic, https://academic.oup.com/nar/article/45/11/6881/3787808
44.
The
Chemistry Behind mRNA Stability - Number Analytics, https://www.numberanalytics.com/blog/chemistry-behind-mrna-stability-nucleic-acids
45.
RNA
G-Quadruplex within the 5'-UTR of FEN1 Regulates mRNA Stability under Oxidative
Stress - PubMed, https://pubmed.ncbi.nlm.nih.gov/36829835/
46.
The
epitranscriptome in ageing and stress resistance: A systematic review - PubMed,
https://pubmed.ncbi.nlm.nih.gov/35908668/
47.
Dawn
of Epitranscriptomic Medicine | Circulation - American Heart Association
Journals, https://www.ahajournals.org/doi/10.1161/CIRCGEN.118.001927
48.
Regulatory
role and mechanism of m6A RNA modification in human metabolic diseases, https://pmc.ncbi.nlm.nih.gov/articles/PMC8399361/
49.
Epitranscriptomics
in the Heart: A Focus on m6A - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC7486268/
50.
Context-Dependent
Roles of RNA Modifications in Stress Responses and Diseases - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC7920320/
51.
Decoding
RNA Metabolism in Disease - Number Analytics, https://www.numberanalytics.com/blog/rna-metabolism-disease-transcriptomics
52.
Metabolic
Stress and Somatic Mutation: Exploring Links to Sleep Disorders, https://ntrs.nasa.gov/citations/20250002640
53.
New
developments in AMPK and mTORC1 cross-talk | Essays in Biochemistry, https://portlandpress.com/essaysbiochem/article/68/3/321/234702/New-developments-in-AMPK-and-mTORC1-cross-talk
54.
Insight
on Transcriptional Regulation of the Energy Sensing AMPK and Biosynthetic mTOR
Pathway Genes - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC7438746/
55.
RNA
dysregulation in neurodegenerative diseases - PMC - PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC11790913/
56.
Deregulated
transcription factors in cancer cell metabolisms and reprogramming - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC11220368/
57.
RNA-based
therapies in liver metabolic diseases - PubMed, https://pubmed.ncbi.nlm.nih.gov/39988358/
